Jay Heinecke - Publications

Washington University, Saint Louis, St. Louis, MO 

82 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2016 Henderson JP, Heinecke JW. Myeloperoxidase and eosinophil peroxidase: Phagocyte enzymes for halogenation in humans Handbook of Environmental Chemistry. 3: 201-214. DOI: 10.1007/b10448  0.318
2015 Rosenson RS, Brewer HB, Ansell BJ, Barter P, Chapman MJ, Heinecke JW, Kontush A, Tall AR, Webb NR. Dysfunctional HDL and atherosclerotic cardiovascular disease. Nature Reviews. Cardiology. PMID 26323267 DOI: 10.1038/nrcardio.2015.124  0.306
2014 Lee JT, Pamir N, Liu NC, Kirk EA, Averill MM, Becker L, Larson I, Hagman DK, Foster-Schubert KE, van Yserloo B, Bornfeldt KE, LeBoeuf RC, Kratz M, Heinecke JW. Macrophage metalloelastase (MMP12) regulates adipose tissue expansion, insulin sensitivity, and expression of inducible nitric oxide synthase. Endocrinology. 155: 3409-20. PMID 24914938 DOI: 10.1210/En.2014-1037  0.334
2014 Smith CK, Vivekanandan-Giri A, Tang C, Knight JS, Mathew A, Padilla RL, Gillespie BW, Carmona-Rivera C, Liu X, Subramanian V, Hasni S, Thompson PR, Heinecke JW, Saran R, Pennathur S, et al. Neutrophil extracellular trap-derived enzymes oxidize high-density lipoprotein: an additional proatherogenic mechanism in systemic lupus erythematosus. Arthritis & Rheumatology (Hoboken, N.J.). 66: 2532-44. PMID 24838349 DOI: 10.1002/Art.38703  0.327
2012 Li J, Wang JJ, Peng Q, Chen C, Humphrey MB, Heinecke J, Zhang SX. Macrophage metalloelastase (MMP-12) deficiency mitigates retinal inflammation and pathological angiogenesis in ischemic retinopathy. Plos One. 7: e52699. PMID 23285156 DOI: 10.1371/Journal.Pone.0052699  0.405
2012 Shao B, Pennathur S, Heinecke JW. Myeloperoxidase targets apolipoprotein A-I, the major high density lipoprotein protein, for site-specific oxidation in human atherosclerotic lesions. The Journal of Biological Chemistry. 287: 6375-86. PMID 22219194 DOI: 10.1074/jbc.M111.337345  0.331
2012 Elsøe S, Ahnström J, Christoffersen C, Hoofnagle AN, Plomgaard P, Heinecke JW, Binder CJ, Björkbacka H, Dahlbäck B, Nielsen LB. Apolipoprotein M binds oxidized phospholipids and increases the antioxidant effect of HDL. Atherosclerosis. 221: 91-7. PMID 22204862 DOI: 10.1016/J.Atherosclerosis.2011.11.031  0.31
2011 Shao B, Heinecke JW. Impact of HDL oxidation by the myeloperoxidase system on sterol efflux by the ABCA1 pathway. Journal of Proteomics. 74: 2289-99. PMID 21501700 DOI: 10.1016/j.jprot.2011.04.001  0.36
2011 Heinecke J. HDL and cardiovascular-disease risk--time for a new approach? The New England Journal of Medicine. 364: 170-1. PMID 21226584 DOI: 10.1056/Nejme1012520  0.331
2010 Shao B, Pennathur S, Pagani I, Oda MN, Witztum JL, Oram JF, Heinecke JW. Modifying apolipoprotein A-I by malondialdehyde, but not by an array of other reactive carbonyls, blocks cholesterol efflux by the ABCA1 pathway. The Journal of Biological Chemistry. 285: 18473-84. PMID 20378541 DOI: 10.1074/Jbc.M110.118182  0.315
2010 Crouch EC, Hirche TO, Shao B, Boxio R, Wartelle J, Benabid R, McDonald B, Heinecke J, Matalon S, Belaaouaj A. Myeloperoxidase-dependent inactivation of surfactant protein D in vitro and in vivo. The Journal of Biological Chemistry. 285: 16757-70. PMID 20228064 DOI: 10.1074/Jbc.M109.097048  0.336
2010 Shao B, Tang C, Heinecke JW, Oram JF. Oxidation of apolipoprotein A-I by myeloperoxidase impairs the initial interactions with ABCA1 required for signaling and cholesterol export. Journal of Lipid Research. 51: 1849-58. PMID 20064972 DOI: 10.1194/jlr.M004085  0.313
2010 Shao B, Oda MN, Oram JF, Heinecke JW. Myeloperoxidase: an oxidative pathway for generating dysfunctional high-density lipoprotein. Chemical Research in Toxicology. 23: 447-54. PMID 20043647 DOI: 10.1021/tx9003775  0.366
2009 Rosen H, Klebanoff SJ, Wang Y, Brot N, Heinecke JW, Fu X. Methionine oxidation contributes to bacterial killing by the myeloperoxidase system of neutrophils. Proceedings of the National Academy of Sciences of the United States of America. 106: 18686-91. PMID 19833874 DOI: 10.1073/pnas.0909464106  0.356
2009 Okamura DM, Pennathur S, Pasichnyk K, López-Guisa JM, Collins S, Febbraio M, Heinecke J, Eddy AA. CD36 regulates oxidative stress and inflammation in hypercholesterolemic CKD. Journal of the American Society of Nephrology : Jasn. 20: 495-505. PMID 19211715 DOI: 10.1681/Asn.2008010009  0.349
2009 Vaisar T, Kassim SY, Gomez IG, Green PS, Hargarten S, Gough PJ, Parks WC, Wilson CL, Raines EW, Heinecke JW. MMP-9 sheds the beta2 integrin subunit (CD18) from macrophages. Molecular & Cellular Proteomics : McP. 8: 1044-60. PMID 19116209 DOI: 10.1074/Mcp.M800449-Mcp200  0.737
2009 Heinecke JW. The HDL proteome: a marker--and perhaps mediator--of coronary artery disease. Journal of Lipid Research. 50: S167-71. PMID 19060251 DOI: 10.1194/jlr.R800097-JLR200  0.325
2009 Wang XS, Shao B, Oda MN, Heinecke JW, Mahler S, Stocker R. A sensitive and specific ELISA detects methionine sulfoxide-containing apolipoprotein A-I in HDL. Journal of Lipid Research. 50: 586-94. PMID 18832772 DOI: 10.1194/jlr.D800042-JLR200  0.359
2008 Shao B, Cavigiolio G, Brot N, Oda MN, Heinecke JW. Methionine oxidation impairs reverse cholesterol transport by apolipoprotein A-I. Proceedings of the National Academy of Sciences of the United States of America. 105: 12224-9. PMID 18719109 DOI: 10.1073/pnas.0802025105  0.369
2008 Shao B, Heinecke JW. Using tandem mass spectrometry to quantify site-specific chlorination and nitration of proteins: model system studies with high-density lipoprotein oxidized by myeloperoxidase. Methods in Enzymology. 440: 33-63. PMID 18423210 DOI: 10.1016/S0076-6879(07)00803-8  0.385
2008 Fu X, Parks WC, Heinecke JW. Activation and silencing of matrix metalloproteinases. Seminars in Cell & Developmental Biology. 19: 2-13. PMID 17689277 DOI: 10.1016/j.semcdb.2007.06.005  0.332
2007 Heinecke JW. The role of myeloperoxidase in HDL oxidation and atherogenesis. Current Atherosclerosis Reports. 9: 249-51. PMID 18173946 DOI: 10.1007/s11883-007-0027-2  0.316
2007 Vaisar T, Shao B, Green PS, Oda MN, Oram JF, Heinecke JW. Myeloperoxidase and inflammatory proteins: pathways for generating dysfunctional high-density lipoprotein in humans. Current Atherosclerosis Reports. 9: 417-24. PMID 18001626 DOI: 10.1007/s11883-007-0054-z  0.347
2007 Wang Y, Rosen H, Madtes DK, Shao B, Martin TR, Heinecke JW, Fu X. Myeloperoxidase inactivates TIMP-1 by oxidizing its N-terminal cysteine residue: an oxidative mechanism for regulating proteolysis during inflammation. The Journal of Biological Chemistry. 282: 31826-34. PMID 17726014 DOI: 10.1074/jbc.M704894200  0.411
2007 Vaisar T, Pennathur S, Green PS, Gharib SA, Hoofnagle AN, Cheung MC, Byun J, Vuletic S, Kassim S, Singh P, Chea H, Knopp RH, Brunzell J, Geary R, Chait A, ... ... Heinecke JW, et al. Shotgun proteomics implicates protease inhibition and complement activation in the antiinflammatory properties of HDL. The Journal of Clinical Investigation. 117: 746-56. PMID 17332893 DOI: 10.1172/Jci26206  0.736
2006 Shao B, Oda MN, Vaisar T, Oram JF, Heinecke JW. Pathways for oxidation of high-density lipoprotein in human cardiovascular disease. Current Opinion in Molecular Therapeutics. 8: 198-205. PMID 16774039  0.399
2006 Gaut JP, Belaaouaj A, Byun J, Roberts LJ, Maeda N, Frei B, Heinecke JW. Vitamin C fails to protect amino acids and lipids from oxidation during acute inflammation. Free Radical Biology & Medicine. 40: 1494-501. PMID 16632110 DOI: 10.1016/J.Freeradbiomed.2005.12.013  0.655
2006 Shao B, Oda MN, Bergt C, Fu X, Green PS, Brot N, Oram JF, Heinecke JW. Myeloperoxidase impairs ABCA1-dependent cholesterol efflux through methionine oxidation and site-specific tyrosine chlorination of apolipoprotein A-I. The Journal of Biological Chemistry. 281: 9001-4. PMID 16497665 DOI: 10.1074/jbc.C600011200  0.376
2006 Takeshita J, Byun J, Nhan TQ, Pritchard DK, Pennathur S, Schwartz SM, Chait A, Heinecke JW. Myeloperoxidase generates 5-chlorouracil in human atherosclerotic tissue: a potential pathway for somatic mutagenesis by macrophages. The Journal of Biological Chemistry. 281: 3096-104. PMID 16326702 DOI: 10.1074/Jbc.M509236200  0.569
2005 Shao B, O'brien KD, McDonald TO, Fu X, Oram JF, Uchida K, Heinecke JW. Acrolein modifies apolipoprotein A-I in the human artery wall. Annals of the New York Academy of Sciences. 1043: 396-403. PMID 16037261 DOI: 10.1196/annals.1333.046  0.304
2005 Kassim SY, Fu X, Liles WC, Shapiro SD, Parks WC, Heinecke JW. NADPH oxidase restrains the matrix metalloproteinase activity of macrophages. The Journal of Biological Chemistry. 280: 30201-5. PMID 15983040 DOI: 10.1074/Jbc.M503292200  0.758
2005 Shao B, Belaaouaj A, Verlinde CL, Fu X, Heinecke JW. Methionine sulfoxide and proteolytic cleavage contribute to the inactivation of cathepsin G by hypochlorous acid: an oxidative mechanism for regulation of serine proteinases by myeloperoxidase. The Journal of Biological Chemistry. 280: 29311-21. PMID 15967795 DOI: 10.1074/Jbc.M504040200  0.313
2005 McMillen TS, Heinecke JW, LeBoeuf RC. Expression of human myeloperoxidase by macrophages promotes atherosclerosis in mice. Circulation. 111: 2798-804. PMID 15911707 DOI: 10.1161/Circulationaha.104.516278  0.31
2005 Pennathur S, Ido Y, Heller JI, Byun J, Danda R, Pergola P, Williamson JR, Heinecke JW. Reactive carbonyls and polyunsaturated fatty acids produce a hydroxyl radical-like species: a potential pathway for oxidative damage of retinal proteins in diabetes. The Journal of Biological Chemistry. 280: 22706-14. PMID 15855169 DOI: 10.1074/jbc.M500839200  0.301
2005 Hirche TO, Gaut JP, Heinecke JW, Belaaouaj A. Myeloperoxidase plays critical roles in killing Klebsiella pneumoniae and inactivating neutrophil elastase: effects on host defense. Journal of Immunology (Baltimore, Md. : 1950). 174: 1557-65. PMID 15661916 DOI: 10.4049/Jimmunol.174.3.1557  0.642
2005 Shao B, Bergt C, Fu X, Green P, Voss JC, Oda MN, Oram JF, Heinecke JW. Tyrosine 192 in apolipoprotein A-I is the major site of nitration and chlorination by myeloperoxidase, but only chlorination markedly impairs ABCA1-dependent cholesterol transport. The Journal of Biological Chemistry. 280: 5983-93. PMID 15574409 DOI: 10.1074/Jbc.M411484200  0.332
2005 Aprikyan AA, Vaisar T, Makaryan V, Heinecke J. A Model of Severe Congenital Neutropenia Reveals Signaling Pathways Mediating Mutant Elastase-Triggered Agranulocytosis. Blood. 106: 3070-3070. DOI: 10.1182/Blood.V106.11.3070.3070  0.304
2005 Hirche T, Gaut J, Heinecke J, Wagner T, Belaaouaj A. Myeloperoxidase/Hypochlorsäure hemmt die enzymatische Aktivität der neutrophilen Serin-Proteinasen Pneumologie. 59. DOI: 10.1055/s-2005-864541  0.532
2004 Bergt C, Pennathur S, Fu X, Byun J, O'Brien K, McDonald TO, Singh P, Anantharamaiah GM, Chait A, Brunzell J, Geary RL, Oram JF, Heinecke JW. The myeloperoxidase product hypochlorous acid oxidizes HDL in the human artery wall and impairs ABCA1-dependent cholesterol transport. Proceedings of the National Academy of Sciences of the United States of America. 101: 13032-7. PMID 15326314 DOI: 10.1073/Pnas.0405292101  0.345
2004 Pennathur S, Bergt C, Shao B, Byun J, Kassim SY, Singh P, Green PS, McDonald TO, Brunzell J, Chait A, Oram JF, O'brien K, Geary RL, Heinecke JW. Human atherosclerotic intima and blood of patients with established coronary artery disease contain high density lipoprotein damaged by reactive nitrogen species. The Journal of Biological Chemistry. 279: 42977-83. PMID 15292228 DOI: 10.1074/Jbc.M406762200  0.744
2004 Fu X, Kao JL, Bergt C, Kassim SY, Huq NP, d'Avignon A, Parks WC, Mecham RP, Heinecke JW. Oxidative cross-linking of tryptophan to glycine restrains matrix metalloproteinase activity: specific structural motifs control protein oxidation. The Journal of Biological Chemistry. 279: 6209-12. PMID 14670964 DOI: 10.1074/Jbc.C300506200  0.771
2004 Bergt C, Fu X, Huq NP, Kao J, Heinecke JW. Lysine residues direct the chlorination of tyrosines in YXXK motifs of apolipoprotein A-I when hypochlorous acid oxidizes high density lipoprotein. The Journal of Biological Chemistry. 279: 7856-66. PMID 14660678 DOI: 10.1074/jbc.M309046200  0.354
2003 Anderson MM, Heinecke JW. Production of N(epsilon)-(carboxymethyl)lysine is impaired in mice deficient in NADPH oxidase: a role for phagocyte-derived oxidants in the formation of advanced glycation end products during inflammation. Diabetes. 52: 2137-43. PMID 12882933 DOI: 10.2337/diabetes.52.8.2137  0.332
2003 Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid generated by myeloperoxidase modifies adjacent tryptophan and glycine residues in the catalytic domain of matrix metalloproteinase-7 (matrilysin): an oxidative mechanism for restraining proteolytic activity during inflammation. The Journal of Biological Chemistry. 278: 28403-9. PMID 12759346 DOI: 10.1074/Jbc.M304739200  0.772
2003 Henderson JP, Byun J, Takeshita J, Heinecke JW. Phagocytes produce 5-chlorouracil and 5-bromouracil, two mutagenic products of myeloperoxidase, in human inflammatory tissue. The Journal of Biological Chemistry. 278: 23522-8. PMID 12707270 DOI: 10.1074/Jbc.M303928200  0.548
2003 Heinecke JW. Oxidative stress: new approaches to diagnosis and prognosis in atherosclerosis. The American Journal of Cardiology. 91: 12A-16A. PMID 12645639 DOI: 10.1016/S0002-9149(02)03145-4  0.373
2002 Heinecke JW. Tyrosyl radical production by myeloperoxidase: a phagocyte pathway for lipid peroxidation and dityrosine cross-linking of proteins. Toxicology. 177: 11-22. PMID 12126792 DOI: 10.1016/S0300-483X(02)00192-0  0.304
2002 Heinecke JW. Oxidized amino acids: culprits in human atherosclerosis and indicators of oxidative stress. Free Radical Biology & Medicine. 32: 1090-101. PMID 12031894 DOI: 10.1016/S0891-5849(02)00792-X  0.371
2002 Gaut JP, Byun J, Tran HD, Lauber WM, Carroll JA, Hotchkiss RS, Belaaouaj A, Heinecke JW. Myeloperoxidase produces nitrating oxidants in vivo. The Journal of Clinical Investigation. 109: 1311-9. PMID 12021246 DOI: 10.1172/Jci15021  0.621
2002 Fu X, Mueller DM, Heinecke JW. Generation of intramolecular and intermolecular sulfenamides, sulfinamides, and sulfonamides by hypochlorous acid: a potential pathway for oxidative cross-linking of low-density lipoprotein by myeloperoxidase. Biochemistry. 41: 1293-301. PMID 11802729 DOI: 10.1021/bi015777z  0.307
2002 Gaut JP, Byun J, Tran HD, Heinecke JW. Artifact-free quantification of free 3-chlorotyrosine, 3-bromotyrosine, and 3-nitrotyrosine in human plasma by electron capture-negative chemical ionization gas chromatography mass spectrometry and liquid chromatography-electrospray ionization tandem mass spectrometry. Analytical Biochemistry. 300: 252-9. PMID 11779118 DOI: 10.1006/Abio.2001.5469  0.575
2001 Gaut JP, Heinecke JW. Mechanisms for oxidizing low-density lipoprotein. Insights from patterns of oxidation products in the artery wall and from mouse models of atherosclerosis. Trends in Cardiovascular Medicine. 11: 103-12. PMID 11685998 DOI: 10.1016/S1050-1738(01)00101-3  0.647
2001 Gaut JP, Yeh GC, Tran HD, Byun J, Henderson JP, Richter GM, Brennan ML, Lusis AJ, Belaaouaj A, Hotchkiss RS, Heinecke JW. Neutrophils employ the myeloperoxidase system to generate antimicrobial brominating and chlorinating oxidants during sepsis. Proceedings of the National Academy of Sciences of the United States of America. 98: 11961-6. PMID 11593004 DOI: 10.1073/Pnas.211190298  0.627
2001 Fu X, Kassim SY, Parks WC, Heinecke JW. Hypochlorous acid oxygenates the cysteine switch domain of pro-matrilysin (MMP-7). A mechanism for matrix metalloproteinase activation and atherosclerotic plaque rupture by myeloperoxidase. The Journal of Biological Chemistry. 276: 41279-87. PMID 11533038 DOI: 10.1074/Jbc.M106958200  0.768
2001 Bergt C, Marsche G, Panzenboeck U, Heinecke JW, Malle E, Sattler W. Human neutrophils employ the myeloperoxidase/hydrogen peroxide/chloride system to oxidatively damage apolipoprotein A-I. European Journal of Biochemistry / Febs. 268: 3523-31. PMID 11422382 DOI: 10.1046/j.1432-1327.2001.02253.x  0.411
2001 Henderson JP, Byun J, Mueller DM, Heinecke JW. The eosinophil peroxidase-hydrogen peroxide-bromide system of human eosinophils generates 5-bromouracil, a mutagenic thymine analogue. Biochemistry. 40: 2052-9. PMID 11329272 DOI: 10.1021/Bi002015F  0.302
2001 Brennan ML, Anderson MM, Shih DM, Qu XD, Wang X, Mehta AC, Lim LL, Shi W, Hazen SL, Jacob JS, Crowley JR, Heinecke JW, Lusis AJ. Increased atherosclerosis in myeloperoxidase-deficient mice. The Journal of Clinical Investigation. 107: 419-30. PMID 11181641 DOI: 10.1172/Jci8797  0.339
2000 Hazen SL, Gaut JP, Crowley JR, Hsu FF, Heinecke JW. Elevated levels of protein-bound p-hydroxyphenylacetaldehyde, an amino-acid-derived aldehyde generated by myeloperoxidase, are present in human fatty streaks, intermediate lesions and advanced atherosclerotic lesions. The Biochemical Journal. 352: 693-9. PMID 11104675 DOI: 10.1042/0264-6021:3520693  0.649
2000 Kirk EA, Dinauer MC, Rosen H, Chait A, Heinecke JW, LeBoeuf RC. Impaired superoxide production due to a deficiency in phagocyte NADPH oxidase fails to inhibit atherosclerosis in mice. Arteriosclerosis, Thrombosis, and Vascular Biology. 20: 1529-35. PMID 10845868 DOI: 10.1161/01.Atv.20.6.1529  0.329
2000 Heller JI, Crowley JR, Hazen SL, Salvay DM, Wagner P, Pennathur S, Heinecke JW. p-hydroxyphenylacetaldehyde, an aldehyde generated by myeloperoxidase, modifies phospholipid amino groups of low density lipoprotein in human atherosclerotic intima. The Journal of Biological Chemistry. 275: 9957-62. PMID 10744670 DOI: 10.1074/Jbc.275.14.9957  0.386
1999 Anderson MM, Requena JR, Crowley JR, Thorpe SR, Heinecke JW. The myeloperoxidase system of human phagocytes generates Nepsilon-(carboxymethyl)lysine on proteins: a mechanism for producing advanced glycation end products at sites of inflammation. The Journal of Clinical Investigation. 104: 103-13. PMID 10393704 DOI: 10.1172/JCI3042  0.308
1999 Heinecke JW. Mass spectrometric quantification of amino acid oxidation products in proteins: insights into pathways that promote LDL oxidation in the human artery wall. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 13: 1113-20. PMID 10385603 DOI: 10.1096/fasebj.13.10.1113  0.338
1999 Whitman SC, Hazen SL, Miller DB, Hegele RA, Heinecke JW, Huff MW. Modification of type III VLDL, their remnants, and VLDL from ApoE-knockout mice by p-hydroxyphenylacetaldehyde, a product of myeloperoxidase activity, causes marked cholesteryl ester accumulation in macrophages. Arteriosclerosis, Thrombosis, and Vascular Biology. 19: 1238-49. PMID 10323775 DOI: 10.1161/01.Atv.19.5.1238  0.353
1999 Byun J, Henderson JP, Mueller DM, Heinecke JW. 8-Nitro-2'-deoxyguanosine, a specific marker of oxidation by reactive nitrogen species, is generated by the myeloperoxidase-hydrogen peroxide-nitrite system of activated human phagocytes. Biochemistry. 38: 2590-600. PMID 10029554 DOI: 10.1021/bi9822980  0.333
1999 Heinecke JW, Hsu FF, Crowley JR, Hazen SL, Leeuwenburgh C, Mueller DM, Rasmussen JE, Turk J. Detecting oxidative modification of biomolecules with isotope dilution mass spectrometry: sensitive and quantitative assays for oxidized amino acids in proteins and tissues. Methods in Enzymology. 300: 124-44. PMID 9919517 DOI: 10.1016/S0076-6879(99)00121-4  0.32
1999 Hazen SL, Hsu FF, Gaut JP, Crowley JR, Heinecke JW. Modification of proteins and lipids by myeloperoxidase. Methods in Enzymology. 300: 88-105. PMID 9919513 DOI: 10.1016/S0076-6879(99)00117-2  0.669
1998 McCormick ML, Gaut JP, Lin TS, Britigan BE, Buettner GR, Heinecke JW. Electron paramagnetic resonance detection of free tyrosyl radical generated by myeloperoxidase, lactoperoxidase, and horseradish peroxidase. The Journal of Biological Chemistry. 273: 32030-7. PMID 9822676 DOI: 10.1074/Jbc.273.48.32030  0.6
1998 Crowley JR, Yarasheski K, Leeuwenburgh C, Turk J, Heinecke JW. Isotope dilution mass spectrometric quantification of 3-nitrotyrosine in proteins and tissues is facilitated by reduction to 3-aminotyrosine. Analytical Biochemistry. 259: 127-35. PMID 9606153 DOI: 10.1006/Abio.1998.2635  0.305
1997 Hazen SL, Crowley JR, Mueller DM, Heinecke JW. Mass spectrometric quantification of 3-chlorotyrosine in human tissues with attomole sensitivity: a sensitive and specific marker for myeloperoxidase-catalyzed chlorination at sites of inflammation. Free Radical Biology & Medicine. 23: 909-16. PMID 9378370 DOI: 10.1016/S0891-5849(97)00084-1  0.325
1997 Hazen SL, Gaut JP, Hsu FF, Crowley JR, d'Avignon A, Heinecke JW. p-Hydroxyphenylacetaldehyde, the major product of L-tyrosine oxidation by the myeloperoxidase-H2O2-chloride system of phagocytes, covalently modifies epsilon-amino groups of protein lysine residues. The Journal of Biological Chemistry. 272: 16990-8. PMID 9202012 DOI: 10.1074/Jbc.272.27.16990  0.629
1997 Hazen SL, Heinecke JW. 3-Chlorotyrosine, a specific marker of myeloperoxidase-catalyzed oxidation, is markedly elevated in low density lipoprotein isolated from human atherosclerotic intima. The Journal of Clinical Investigation. 99: 2075-81. PMID 9151778 DOI: 10.1172/Jci119379  0.397
1997 Leeuwenburgh C, Hardy MM, Hazen SL, Wagner P, Oh-ishi S, Steinbrecher UP, Heinecke JW. Reactive nitrogen intermediates promote low density lipoprotein oxidation in human atherosclerotic intima. The Journal of Biological Chemistry. 272: 1433-6. PMID 8999808 DOI: 10.1074/Jbc.272.3.1433  0.388
1996 Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. The Journal of Clinical Investigation. 98: 1283-9. PMID 8823292 DOI: 10.1172/Jci118914  0.3
1996 Hazen SL, Hsu FF, Duffin K, Heinecke JW. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes converts low density lipoprotein cholesterol into a family of chlorinated sterols. The Journal of Biological Chemistry. 271: 23080-8. PMID 8798498 DOI: 10.1074/Jbc.271.38.23080  0.306
1996 Berliner JA, Heinecke JW. The role of oxidized lipoproteins in atherogenesis. Free Radical Biology & Medicine. 20: 707-27. PMID 8721615 DOI: 10.1016/0891-5849(95)02173-6  0.365
1996 Jacob JS, Cistola DP, Hsu FF, Muzaffar S, Mueller DM, Hazen SL, Heinecke JW. Human phagocytes employ the myeloperoxidase-hydrogen peroxide system to synthesize dityrosine, trityrosine, pulcherosine, and isodityrosine by a tyrosyl radical-dependent pathway. The Journal of Biological Chemistry. 271: 19950-6. PMID 8702710 DOI: 10.1074/Jbc.271.33.19950  0.351
1994 Heinecke JW. Cellular mechanisms for the oxidative modification of lipoproteins: implications for atherogenesis. Coronary Artery Disease. 5: 205-10. PMID 8199734 DOI: 10.1097/00019501-199403000-00004  0.31
1994 Daugherty A, Dunn JL, Rateri DL, Heinecke JW. Myeloperoxidase, a catalyst for lipoprotein oxidation, is expressed in human atherosclerotic lesions. The Journal of Clinical Investigation. 94: 437-44. PMID 8040285 DOI: 10.1172/JCI117342  0.346
1994 Chait A, Heinecke JW. Lipoprotein modification: cellular mechanisms. Current Opinion in Lipidology. 5: 365-70. PMID 7858911 DOI: 10.1097/00041433-199410000-00008  0.325
1993 Heinecke JW, Li W, Francis GA, Goldstein JA. Tyrosyl radical generated by myeloperoxidase catalyzes the oxidative cross-linking of proteins. The Journal of Clinical Investigation. 91: 2866-72. PMID 8390491 DOI: 10.1172/JCI116531  0.315
1993 Francis GA, Mendez AJ, Bierman EL, Heinecke JW. Oxidative tyrosylation of high density lipoprotein by peroxidase enhances cholesterol removal from cultured fibroblasts and macrophage foam cells. Proceedings of the National Academy of Sciences of the United States of America. 90: 6631-5. PMID 8341680 DOI: 10.1073/Pnas.90.14.6631  0.317
1987 Hiramatsu K, Rosen H, Heinecke JW, Wolfbauer G, Chait A. Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis (Dallas, Tex.). 7: 55-60. PMID 3028347 DOI: 10.1161/01.ATV.7.1.55  0.327
Show low-probability matches.